ArticleNature biomedical engineering2026
Symbiotic transcatheter pacemaker for lifelong energy regeneration and therapeutic function in porcine disease model.
Article in Nature biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Self-sustaining leadless intracardiac pacemaker powered by triboelectric nanogenerator.Science advances · 2026Article
- Engineering trustworthy closed-loop bioelectronic systems for cardiovascular disease.Innovation (Cambridge (Mass.)) · 2026Review
- Restoration of endogenous electric fields with a glucose-powered symbiotic bioabsorbable bandage for diabetic wound healing.Science advances · 2026Article
- Electroactive microneedle augmented stem cell therapy in myocardial infarction.Science advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Funding
Abstract
Lifelong pacing is one of the ultimate goals of cardiac pacemakers. However, meeting the critical energy condition for lifelong service is a tremendous challenge. Here we report a symbiotic transcatheter pacemaker that regenerates electric energy from heart motion via electromagnetic induction and surpasses the critical energy condition for lifelong service. The pacemaker can be closely integrated with the body owing to favourable biocompatibility and hemocompatibility, and its small size enables interventional delivery. To minimize energy loss and eliminate mechanical collision and friction, we propose a straightforward magnetic levitation energy cache structure. The energy regeneration module has a near-zero boot threshold, high kinetic energy conversion efficiency and intracardiac root mean square output power. We show the energy regeneration and therapeutic function of the symbiotic transcatheter pacemaker over a month-long autonomous operation in a porcine model of brady-arrhythmia. These advances may provide a potential path to extend the service life of pacemakers to the level of the natural heart.
Identifiers
41554938What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.